Drug class
Calcineurin Inhibitors clinical trials
A class of medicines: the studies that test any of its 3 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.
Keep track of what changes. Save the calcineurin inhibitors studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesMedicines in this class
Studies that test each. A study of two counts under both, and once above.
Studies by the year they started
975 studies that test it; most in 2004 (68)
| Year | Studies |
|---|---|
| 1990 | 1 |
| 1995 | 3 |
| 1996 | 4 |
| 1997 | 7 |
| 1998 | 9 |
| 1999 | 14 |
| 2000 | 21 |
| 2001 | 17 |
| 2002 | 35 |
| 2003 | 36 |
| 2004 | 68 |
| 2005 | 46 |
| 2006 | 57 |
| 2007 | 46 |
| 2008 | 40 |
| 2009 | 40 |
| 2010 | 52 |
| 2011 | 42 |
| 2012 | 38 |
| 2013 | 32 |
| 2014 | 34 |
| 2015 | 40 |
| 2016 | 30 |
| 2017 | 36 |
| 2018 | 27 |
| 2019 | 30 |
| 2020 | 47 |
| 2021 | 20 |
| 2022 | 20 |
| 2023 | 18 |
| 2024 | 17 |
| 2025 | 24 |
| 2026 | 24 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 300 · Other 695
Astellas Pharma Inc (83) · Fred Hutchinson Cancer Center (44) · Novartis Pharmaceuticals (26) · Novartis (26) · National Heart, Lung, and Blood Institute (NHLBI) (16) · National Institute of Allergy and Infectious Diseases (NIAID) (15) · National Cancer Institute (NCI) (14) · M.D. Anderson Cancer Center (14)
Studies
Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.
Testing one of them · 995
- Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood CancersNot yet recruitingPhase 2National Cancer Institute (NCI)NCT07524530Written as Tacrolimus
- Rituximab Plus Cyclosporine in Idiopathic Membranous NephropathyRecruitingPhase 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT00977977Written as Oral Cyclosporine
- Advancing Transplantation Outcomes in ChildrenRecruitingPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT06055608Written as Tacrolimus (Group1)
- TRACK-TBI Precision Medicine Part 3 - Option IIEnrolling by invitationPhase 2University of California, San FranciscoNCT06790095Written as Cyclosporine (CsA)
- Allogeneic Hematopoietic Stem Cell Transplant for GATA2 MutationsRecruitingPhase 2National Cancer Institute (NCI)NCT01861106Written as Tacrolimus
- Osimertinib and Cyclosporine A to Enhance Antitumor Efficacy in NSCLCRecruitingPhase 2NYU Langone HealthNCT07874490Written as Cyclosporine A (CsA)
- Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic SyndromeRecruitingPhase 2City of Hope Medical CenterNCT06128070Written as Tacrolimus
- Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant CyclophosphamideRecruitingPhase 2Northside Hospital, Inc.NCT06828796Written as Tacrolimus
- A Study to Investigate the Effect of Omeprazole and Cyclosporine on Velzatinib in Healthy ParticipantsNot yet recruitingPhase 1GlaxoSmithKlineNCT07862114Written as Cyclosporine
- Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell TransplantNot yet recruitingPhase 2Stanford UniversityNCT07634536Written as Tacrolimus
- Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)Not yet recruitingPhase 2Case Comprehensive Cancer CenterNCT06084780Written as Tacrolimus
- Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell TransplantationRecruitingPhase 2Hannah Choe, MDNCT07249346Written as Tacrolimus
- Tacrolimus as Prophylaxis of Post-ERCP PancreatitisNot yet recruitingPhase 4Amsterdam UMC, location VUmcNCT07781722Written as Tacrolimus
- TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCTRecruitingPhase 1Stanford UniversityNCT07302776Written as Tacrolimus
- Feasibility Pilot Sequential Multiple Assignment Randomized Trial (SMART) for Acute Severe Ulcerative ColitisRecruitingPhase 4Berinstein, JeffreyNCT05867329Written as Cyclosporine Injection (IV)
- Uterus Transplantation to Treat InfertilityRecruitingPhase 2/3Johns Hopkins UniversityNCT05646992Written as Tacrolimus
- Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior UveitisRecruitingPhase 2Novaliq GmbHNCT07285070Written as Tacrolimus ophthalmic solution
- Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CRRecruitingPhase 2/3University Hospital, AngersNCT02416388Written as Cyclosporine
- Human Penile AllotransplantationRecruitingPhase 2/3Johns Hopkins UniversityNCT02395497Written as Tacrolimus
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingPhase 2NYU Langone HealthNCT07138898Written as Cyclosporine
See all 995 studies that test one of the calcineurin inhibitors →
Codes
What other systems call Calcineurin Inhibitors · ClinicalTrials.gg INT008982
- MeSH (NLM) D065095Calcineurin InhibitorsOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D065095 | Calcineurin Inhibitors | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.